Lifecore Biomedical, Inc. De (LFCR) Net Margin (2010 - 2025)

Lifecore Biomedical's Net Margin history runs 16 years deep, the most recent figure standing at 5.62% for Q2 2025.

• In Q2 2025, Net Margin rose 1308.0% year-over-year to 5.62%; the TTM figure through May 2025 stood at 33.08% (down 5228.0% YoY), while the FY2025 annual figure was 34.42%, down 4379.0% from the prior year.
• Net Margin was 5.62% for Q2 2025 at Lifecore Biomedical, up from 44.53% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 47.16% in Q4 2023 to a low of 183.73% in Q2 2022.
• Historically, Net Margin has averaged 33.29% across 5 years, with a median of 17.22% in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 17909 bps in 2022, then jumped 17639 bps in 2023.
• A 5-year view of Net Margin shows it stood at 179.75% in 2021, then jumped by 91 bps to 16.49% in 2022, then soared by 386 bps to 47.16% in 2023, then sank by 157 bps to 26.73% in 2024, then soared by 79 bps to 5.62% in 2025.
• The last three Net Margin figures came in at 5.62% (Q2 2025), 44.53% (Q1 2025), and 26.73% (Q4 2024), per Business Quant data.